A 10-year follow-up to determine the effect of yag laser iridotomy on the natural history of pigment dispersion syndrome a randomized clinical trial

JAMA Ophthalmology

Volumn 132, Issue 12, 2014, Pages 1433-1438

  Gandolfi, Stefano A ^a   Ungaro, Nicola ^a   Tardini, Maria Grazia ^a   Ghirardini, Stella ^a   Carta, Arturo ^a   Mora, Paolo ^a  

^a UNIVERSITY OF PARMA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PHENYLEPHRINE; MYDRIATIC AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; EVENT FREE SURVIVAL; FOLLOW UP; GLAUCOMA; HIGH RISK PATIENT; HIGH RISK POPULATION; HUMAN; INTRAOCULAR PRESSURE; IRIDOTOMY; ITALY; LASER PERIPHERAL IRIDOTOMY; LOW RISK PATIENT; MAJOR CLINICAL STUDY; NEODYMIUM YAG LASER; OUTCOME ASSESSMENT; PIGMENT DISORDER; PIGMENT DISPERSION SYNDROME; RANDOMIZED CONTROLLED TRIAL; UNIVERSITY HOSPITAL; DIAGNOSTIC USE; DRUG EFFECTS; EXFOLIATION SYNDROME; FEMALE; GLAUCOMA, OPEN-ANGLE; GONIOSCOPY; IRIDECTOMY; IRIS; LOW LEVEL LASER THERAPY; MALE; MIDDLE AGED; OCULAR HYPERTENSION; OCULOPLETHYSMOGRAPHY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; PROSPECTIVE STUDY; SOLID STATE LASER; THERAPEUTIC USE; YOUNG ADULT;

ADULT; EXFOLIATION SYNDROME; FEMALE; FOLLOW-UP STUDIES; GLAUCOMA, OPEN-ANGLE; GONIOSCOPY; HUMANS; INTRAOCULAR PRESSURE; IRIDECTOMY; IRIS; LASER THERAPY; LASERS, SOLID-STATE; MALE; MIDDLE AGED; MYDRIATICS; OCULAR HYPERTENSION; PHENYLEPHRINE; PROSPECTIVE STUDIES; TONOMETRY, OCULAR; YOUNG ADULT;

EID: 84918512564     PISSN: 21686165     EISSN: 21686173     Source Type: Journal    
DOI: 10.1001/jamaophthalmol.2014.3291     Document Type: Article

References (25)

1. Gandolfi SA, Ungaro N, Mora P, Sangermani C. Pigmentary glaucoma. In: Shaarawy TM, Sherwood MB, Hitchings RA, Crowston JG, et al. Glaucoma: Medical Diagnosis and Therapy. Philadelphia, PA: Elsevier-Saunders; 2009:349-360
2. Campbell DG. Pigmentary dispersion and glaucoma. A new theory. Arch Ophthalmol. 1979;97 (9):1667-1672
3. Karickhoff JR. Reverse pupillary block in pigmentary glaucoma: Follow up and new developments. Ophthalmic Surg. 1993;24(8):562-563
4. Pavlin CJ, Harasiewicz K, Foster FS. Posterior iris bowing in pigmentary dispersion syndrome caused by accommodation. Am J Ophthalmol. 1994;118(1): 114-116
5. Carassa RG, Bettin P, FioriM, Brancato R. Nd:YAG laser iridotomy in pigment dispersion syndrome: An ultrasound biomicroscopic study. Br J Ophthalmol. 1998;82(2):150-153
6. Breingan PJ, Esaki K, Ishikawa H, Liebmann JM, Greenfield DS, Ritch R. Iridolenticular contact decreases following laser iridotomy for pigment dispersion syndrome. Arch Ophthalmol. 1999;117 (3):325-328
7. Gandolfi SA, Vecchi M. Effect of a YAG laser iridotomy on intraocular pressure in pigment dispersion syndrome. Ophthalmology. 1996;103 (10):1693-1695
8. Farrar SM, Shields MB, Miller KN, Stoup CM. Risk factors for the development and severity of glaucoma in the pigment dispersion syndrome. Am J Ophthalmol. 1989;108(3):223-229
9. Mitsui Y, Takagi Y. Nature of aqueous floaters due to sympathomimeticmydriasis. Arch Ophthalmol. 1961;65:626-631
10. Epstein DL, Boger WP III, Grant WM. Phenylephrine provocative testing in pigment dispersion syndrome. Am J Ophthalmology. 1978; 85(1):43-50
11. Migliazzo CV, Shaffer RN, Nykin R,Magee S. Long-term analysis of pigmentary dispersion syndrome and pigmentary glaucoma. Ophthalmology. 1986;93(12):1528-1536
12. Farrar SM, Shields MB. Current concepts in pigmentary glaucoma. Surv Ophthalmol. 1993;37 (4):233-252
13. Mora P, Sangermani C, Ghirardini S, Carta A, Ungaro N, Gandolfi S. Ultrasound biomicroscopy and iris pigment dispersion: A case-control study. Br J Ophthalmol. 2010;94(4):428-432
14. Glynn RJ, Rosner B. Regressionmethods when the eye is the unit of analysis. Ophthalmic Epidemiol. 2012;19(3):159-165
15. Niyadurupola N, Broadway DC. Pigment dispersion syndrome and pigmentary glaucoma-a major review. Clin Experiment Ophthalmol. 2008; 36(9):868-882
16. Siddiqui Y, Ten Hulzen RD, Cameron JD, Hodge DO, Johnson DH. What is the risk of developing pigmentary glaucoma from pigment dispersion syndrome? Am J Ophthalmol. 2003;135(6):794-799
17. Scott A, Kotecha A, Bunce C, et al. YAG laser peripheral iridotomy for the prevention of pigment dispersion glaucoma a prospective, randomized, controlled trial. Ophthalmology. 2011;118(3):468-473
18. Richter CU, Richardson TM, Grant WM. Pigmentary dispersion syndrome and pigmentary glaucoma: A prospective study of the natural history. Arch Ophthalmol. 1986;104(2):211-215
19. Campbell DG, Schertzer RM. Pathophysiology of pigment dispersion syndrome and pigmentary glaucoma. Curr Opin Ophthalmol. 1995;6(2):96-101
20. KüchleM, Mardin CY, Nguyen NX, Martus P, Naumann GO. Quantification of aqueous melanin granules in primary pigment dispersion syndrome. Am J Ophthalmol. 1998;126(3):425-431
21. Mardin CY, KüchleM, Nguyen NX, Martus P, Naumann GO. Quantification of aqueous melanin granules, intraocular pressure and glaucomatous damage in primary pigment dispersion syndrome. Ophthalmology. 2000;107(3):435-440
22. Schenker HI, Luntz MH, Kels B, Podos SM. Exercise-induced increase of intraocular pressure in the pigmentary dispersion syndrome. Am J Ophthalmol. 1980;89(4):598-600
23. Lascaratos G, Shah A, Garway-Heath DF. The genetics of pigment dispersion syndrome and pigmentary glaucoma. Surv Ophthalmol. 2013;58 (2):164-175
24. KüchleM, Nguyen NX, Mardin CY, Naumann GO. Effect of neodymium:YAG laser iridotomy on number of aqueous melanin granules in primary pigment dispersion syndrome. Graefes Arch Clin Exp Ophthalmol. 2001;239(6):411-415
25. Reistad CE, Shields MB, Campbell DG, Ritch R, Wang JC,Wand M; American Glaucoma Society Pigmentary Glaucoma Iridotomy Study Group. The influence of peripheral iridotomy on the intraocular pressure course in patients with pigmentary glaucoma. J Glaucoma. 2005;14(4):255-259